1. Home
  2. COEP vs FTHM Comparison

COEP vs FTHM Comparison

Compare COEP & FTHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • FTHM
  • Stock Information
  • Founded
  • COEP 2017
  • FTHM 2010
  • Country
  • COEP United States
  • FTHM United States
  • Employees
  • COEP N/A
  • FTHM N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • FTHM Real Estate
  • Sector
  • COEP Health Care
  • FTHM Finance
  • Exchange
  • COEP Nasdaq
  • FTHM Nasdaq
  • Market Cap
  • COEP 32.4M
  • FTHM 32.8M
  • IPO Year
  • COEP N/A
  • FTHM 2020
  • Fundamental
  • Price
  • COEP $12.45
  • FTHM $1.20
  • Analyst Decision
  • COEP
  • FTHM Strong Buy
  • Analyst Count
  • COEP 0
  • FTHM 4
  • Target Price
  • COEP N/A
  • FTHM $4.25
  • AVG Volume (30 Days)
  • COEP 115.6K
  • FTHM 98.4K
  • Earning Date
  • COEP 03-25-2025
  • FTHM 03-13-2025
  • Dividend Yield
  • COEP N/A
  • FTHM N/A
  • EPS Growth
  • COEP N/A
  • FTHM N/A
  • EPS
  • COEP N/A
  • FTHM N/A
  • Revenue
  • COEP N/A
  • FTHM $317,515,000.00
  • Revenue This Year
  • COEP N/A
  • FTHM N/A
  • Revenue Next Year
  • COEP N/A
  • FTHM $25.84
  • P/E Ratio
  • COEP N/A
  • FTHM N/A
  • Revenue Growth
  • COEP N/A
  • FTHM N/A
  • 52 Week Low
  • COEP $2.31
  • FTHM $1.12
  • 52 Week High
  • COEP $13.70
  • FTHM $3.37
  • Technical
  • Relative Strength Index (RSI)
  • COEP 63.21
  • FTHM 37.94
  • Support Level
  • COEP $8.65
  • FTHM $1.12
  • Resistance Level
  • COEP $12.95
  • FTHM $1.36
  • Average True Range (ATR)
  • COEP 1.64
  • FTHM 0.09
  • MACD
  • COEP -0.16
  • FTHM 0.01
  • Stochastic Oscillator
  • COEP 75.25
  • FTHM 27.07

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About FTHM Fathom Holdings Inc.

Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title.

Share on Social Networks: